Table 2.
Metabolites | Genotype-diet groups relative abundance of metabolites | Significance level for main effects and 2-way interaction as analyzed by a general linear model F(5,24)† | |||||||
---|---|---|---|---|---|---|---|---|---|
|
|
||||||||
Wild-type Basal | Cdo1-null Basal | Wild-type HiFat | Cdo1-null HiFat | Wild-type HiFat + Tau | Cdo1-null HiFat + Tau | Genotype | Diet | GxD | |
Taurine | 1 ± 0.06a*,† | 0.059 ± 0.005b | 0.97 ± 0.10a | 0.047 ± 0.002b | 0.94 ± 0.17a | 1.16 ± 0.06a | p < 0.0001 | p < 0.0001 | p < 0.0001 |
Betaine | 1 ± 0.05b | 2.33 ± 0.13a | 1.16 ± 0.10b | 2.66 ± 0.40a | 1.06 ± 0.10b | 1.38 ± 0.26b | p < 0.0001 | p = 0.0099 | p = 0.0209 |
Choline | 1 ± 0.08b | 1.88 ± 0.11a | 1.04 ± 0.05b | 1.63 ± 0.21a | 1.00 ± 0.01b | 0.83 ± 0.08b | p < 0.0001 | p = 0.0099 | p = 0.0210 |
sn-Glycerol-3-phosphocholine | 1 ± 0.12b | 2.05 ± 0.14a | 1.01 ± 0.08b | 1.83 ± 0.27a | 0.93 ± 0.10b | 0.82 ± 0.12b | p = 0.0010 | p = 0.0006 | p = 0.0038 |
Carnosine | 1 ± 0.05b | 2.26 ± 0.27a | 1.24 ± 0.14b | 2.63 ± 0.17a | 1.08 ± 0.14b | 0.94 ± 0.08b | p < 0.0001 | p < 0.0001 | p = 0.0001 |
myo-Inositol | 1 ± 0.05ab | 1.19 ± 0.06ab | 0.94 ± 0.04b | 1.34 ± 0.15a | 1.05 ± 0.06ab | 1.13 ± 0.08ab | p = 0.0014 | ||
Glucitol/Iditol/Galactitol | 1 ± 0.09a | 0.65 ± 0.08ab | 0.47 ± 0.04b | 0.45 ± 0.02b | 0.46 ± 0.05b | 0.41 ± 0.09b | p = 0.0621 | p = 0.0006 |
All values for metabolite concentrations are expressed relative to the average value for the wild-type/basal diet group, which was set as 1.0. Data are expressed as mean ± SEM
All values were transformed to log10 values prior to statistical analysis. Columns on the right give p values for the main effects and their interaction as analyzed by a general linear model for the two categorical variables and their interaction using JMP, version 11 (SAS, Cary, NC). Values not followed by the same superscript letter are significantly different at p < 0.05 as determined by the Tukey’s post hoc comparison test. Italic values indicates metabolites with concentration changes in response to taurine deficiency